Abstract
Trypanosoma brucei is an extracellular parasite that alternates between an insect vector (procyclic form) and the bloodstream of a mammalian host (bloodstream form). While it was previously reported that mitochondrial release factor 1 (TbMrf1) is essential in cultured procyclic form cells, we demonstrate here that in vitro bloodstream form cells can tolerate the elimination of TbMrf1. Therefore, we explored if this discrepancy is due to the unique bioenergetics of the parasite since procyclic form cells rely on oxidative phosphorylation; whereas bloodstream form cells utilize glycolysis for ATP production and FoF1-ATPase to maintain the essential mitochondrial membrane potential. The observed disruption of intact bloodstream form FoF1-ATPases serves as a proxy to indicate that the translation of its mitochondrially encoded subunit A6 is impaired without TbMrf1. While these null mutants have a decreased mitochondrial membrane potential, they have adapted by increasing their dependence on the electrogenic contributions of the ADP/ATP carrier to maintain the mitochondrial membrane potential above the minimum threshold required for T. brucei viability in vitro. However, this inefficient compensatory mechanism results in avirulent mutants in mice. Finally, the depletion of the codon-independent release factor TbPth4 in the TbMrf1 knockouts further exacerbates the characterized mitchondrial phenotypes.
Similar content being viewed by others
Introduction
Not only are Trypanosoma brucei medically and economically important parasites that cause disease in humans and livestock, but these flagellated protists are also an excellent model to address fundamental questions within eukaryotic cell biology1. One of the most prominent areas of research over the last three decades has focused on the mitochondrial (mt) gene expression of this early divergent eukaryote. Its mt DNA is arranged in an immense network of concatenated large (maxi-) and small (mini-) circular DNA molecules that are condensed into a disc-like structure termed the kinetoplast2. Transcription of the maxicircle DNA generates polycistronic precursors that are processed into two ribosomal RNAs and 18 mRNAs that encode subunits of the mitoribosome and the oxidative phosphorylation complexes. However, to generate functional open reading frames, 12 of these protein-encoding transcripts require further maturation by an RNA editing process that specifically directs the insertion or deletion of uridylate nucleotides (nt)3 with the help of short guide RNAs transcribed from the minicircles4,5. While much of the editing process has been elucidated, little is known about how the T. brucei mitoribosome selectively translates only correctly edited transcripts6,7.
Although mitoribosomes are more closely related to bacterial ribosomes than their eukaryotic cytosolic counterparts, they nonetheless possess shorter mt ribosomal RNA (rRNA) and have acquired additional mitochondrial-specific proteins. The T. brucei mitoribosome represents an extreme example of this evolutionary divergence as it consists of 133 subunits, 56 of which do not have any recognizable homology to components of known mitoribosomes outside the Kinetoplastida group8. Furthermore, the 611 nt 9S rRNA of the mitoribosomal small subunit (SSU) and the 1149 nt 12S rRNA of the large subunit (LSU) are extremely short9,10. The cryo-EM map of a kinetoplastid mitoribosome illustrates that proteins have replaced the loss of key functional rRNA helices11. While the overall size and morphology is comparable to the bacterial ribosome, the structure on average is more porous and the topology of the intersubunit space is remodeled. Furthermore, since the mRNA channel, the tRNA corridors and the nascent polypeptide exit tunnel are all predominantly lined with unique kinetoplastid proteins, it suggests that the specific translational mechanisms employed by the kinetoplastid mitoribosome will vary from the ribosomes examined in other model organisms11.
Noticeably, the T. brucei mt DNA does not encode for any tRNAs; instead, the full complement must be imported from nuclear encoded genes12,13. However, the mt genome does contain a cryptogene for a single ribosomal protein, a homolog of the highly conserved bacterial S12, designated RPS1214. The transcript is extensively edited throughout the open reading frame before it is translated. In the bacterial ribosome, S12 is incorporated into the shoulder of the SSU, near the subunit interface and extends into the decoding center of the SSU aminoacyl tRNA site (A site), where it binds 16S rRNA and plays a critical role in the fidelity of tRNA selection15,16,17. In addition, through its interaction with elongation factors, it acts as a control element in the translocation of the mRNA-tRNA through the ribosome18. A similar indispensable role is assumed for the T. brucei RPS12 because the inactivation of RNA editing leads to the reduction of the 45S SSU-related complex and the 80S mRNA-bound monosome7. Furthermore, while only a few (cytochrome b, cytochrome oxidase subunit 1, FoF1-ATP synthase subunit A6) of the highly hydrophobic proteins translated from the maxicircle transcripts can be reliably detected in just procyclic form parasites19,20, the disruption of RNA editing severely impairs mitochondrial translation. Therefore, it is proposed that RPS12 acts as a functional link between RNA editing and translation in T. brucei7.
Remarkably, due to their complex mt gene expression, several hundreds of proteins are required to synthesize the only two mt encoded proteins (RPS12 and FoF1-ATPase subunit A6) deemed to be essential for the extracellular pathogen to reside in the bloodstream of its mammalian host7,21. While the insect stage (procyclic form, PF) of the parasite depends on the oxidative phosphorylation pathway to generate sufficient quantities of cellular ATP, the bloodstream form (BF) exploits the high glucose content of its surroundings to synthesize ATP through glycolysis22. This bioenergetics adaptation to the varied nutrients available throughout its life cycle results in a dramatic remodeling of the singular mitochondrion. The tubular BF mitochondrion lacks a functional cytochrome-mediated respiratory chain and thus respires through the trypanosome alternative oxidase23,24. Therefore, the FoF1-ATP synthase reverses direction and hydrolyzes ATP to pump protons into the mt inner membrane space, maintaining the essential mt membrane potential (∆ψm)25. This rotary molecular machine is comprised of a catalytic F1 moiety and the membrane embedded Fo domain that contains the proton pore. Proton translocation occurs via interactions between the Fo c-ring and the only mt encoded component of FoF1-ATPase, subunit A6. The A6 transcript of this maxicircle gene is pan-edited in both life cycle stages, but it is only in the reduced BF mitochondrion that a single point mutation in the γ subunit of the F1 central stalk permits the parasite to become mt DNA independent21. Naturally occurring dyskinetoplastic (Dk) trypanosomes that lack a complete mt genome26, have also obtained compensatory mutations that allow the parasite to escape their dependency on the proton pumping function of the FoF1-ATPase. While the hydrolytic function of this enzyme is still essential, there is a greater reliance on the ADP/ATP carrier (TbAAC)27,28 to not only provide ATP substrate, but to also maintain the ∆ψm through the electrogenic exchange of cytosolic ATP4− for mt ADP3−21,29.
Mt translation is a complex process that can be divided into four steps: initiation, elongation, termination and ribosome recycling. Here we focus on translation termination, which occurs when a mt release factor (RF), containing two decoding motifs (α−5 helix and PXT), determines that a mRNA stop codon occupies the ribosomal A site30,31. Upon recognition, the conserved GGQ loop of the RF shifts into the LSU peptidyl-transferase center (PTC) and hydrolyzes the ester bond between the tRNA in the peptidyl tRNA site (P site) and the terminal amino acid of the nascent peptide, thus releasing the protein from the translational apparatus32,33. Most mitochondrial translation systems have a reduced number of termination codons (UAA and UAG) that can be recognized by a single mt release factor (yeast – Mrf1)34. The depletion of Mrf1 in S. cerevisiae, a petite-positive yeast, results in respiratory dysfunction and rapid mt genomic instability, indicating that Mrf1 is essential for mitochondrial translation35. However, the depletion of this ortholog in either mammalian cells or S. pombe, a petite-negative yeast, only leads to a partial respiratory defect because mt protein synthesis is not completely eliminated34. This outcome suggests that another member of the RF family can compensate for the loss of the Mrf1. Indeed, while the depletion of the peptidyl-tRNA hydrolase, Pth4 in S. pombe, does not result in any phenotype, its ablation significantly exacerbates the Δmrf1 phenotype36. Pth4 retains the highly conserved GGQ motif, but it is smaller than standard RFs because it lacks the codon recognition domains37. Instead, it has an unstructured basic residue-rich tail at the C-terminus that is required for ribosomal binding. Unlike other members of the RF family that transiently interact with the ribosomal A site, Pth4 is an integral member of the LSU37,38. Therefore, it has been proposed that Pth4 acts as a codon-independent, mitoribosome-dependent RF that can rescue stalled ribosomes.
Mt translation is required for BF T. brucei viability39, but it presumably serves only to synthesize the essential FoF1-ATPase subunit A6. While TbMrf1 is indispensable in PF T. brucei40, where translation of most of the mt genome is required to generate sufficient ATP via an active oxidative phosphorylation pathway, we determined that the BF parasites grown in culture are able to adapt to life without TbMrf1.
Results
Cultured BF T. brucei tolerate the loss of TbMrf1, displaying only a mild growth phenotype
Due to the limitations of RNAi to wholly silence a gene product, we eliminated both alleles of TbMrf1 (Tb927.03.1070) by homologous recombination. The generation of a viable double knockout TbMrf1 (dKO TbMrf1) cell line indicates that this release factor is not essential for the reduced mitochondrion of BF T. brucei. Lacking a TbMrf1 antibody, we verified the null cells by PCR analysis, incorporating primers designed to bridge each of the integration sites of the selectable markers that replaced both alleles (Fig. 1a). The single knockout (sKO) TbMrf1 cell line contained amplicons of the expected size for the TbMrf1 coding sequence (cds), as well as the 5′ and 3′ integration sites for the T7 polymerase/neomycin cassette (Fig. 1b). Noticeably, the TbMrf1 cds amplicon is not detected in the dKO cell line, while the replacement of both alleles was confirmed. Even though the dKO TbMrf1 cell line is certainly viable, it does have a reduced doubling time compared to the parental cell line (Fig. 1c, Table 1). Furthermore, we observed that dKO Mrf1 cells maintained in culture for 7 weeks had a modified rate of cell proliferation that reverted back towards the values of the wild-type (WT) BF 427 cells. Since these parasites appeared better adjusted to life without TbMrf1, we included this dKO TbMrf1 7wk cell line throughout our phenotypic analyses so they could be compared with the dKO TbMrf1 1wk cell line, which were the first cells to arise during the selection of transfected cells.
The absence of TbMrf1 significantly alters the structural integrity of the protein complexes containing mt encoded subunits
While de novo mt synthesis of cytochrome b, cytochrome oxidase subunit 1 and FoF1-ATP synthase subunit A6 can be observed in PF parasites, none of the highly hydrophobic mt encoded proteins have ever been detected in the BF mitochondrion20. Therefore, to circumvent the dearth of direct assays to measure mt translation in the dKO TbMrf1 cell line, we opted to investigate the structural integrity of the mitoribosomes and FoF1-ATPase. Both of these large molecular complexes contain just a single gene product (RPS12 and A6, respectively) that is synthesized from the mt genome after extensive post-transcriptional editing in BF parasites. To determine how the loss of TbMrf1 affects the mitoribosomes, equal numbers of cells from the parental and dKO TbMrf1 cultures were lysed with 1% Nonidet NP40 and fractionated on a 10–30% glycerol gradient. Total RNA isolated from equal volumes of each fraction was resolved on a 5% polyacrylamide/8 M urea gel and visualized with 9S and 12S rRNA probes (Fig. 2a). To verify that each glycerol gradient created on the Gradient Master from BioComp Instruments produced reproducible sedimentation profiles, the total RNA samples from each fraction were also analyzed with a cytosolic LSU 18S rRNA probe. To compare the amount of rRNA in each fraction between the various cell lines, 8 ug of BF 427 total RNA was included for each northern blot. After normalization to this input, the relative intensity of 9S and 12S rRNA was plotted (Fig. 2b). The drastic decrease in both rRNA molecules throughout the gradient fractions of the dKO TbMrf1 1wk cell line indicates that the translational apparatus has been impaired, as both the LSU and SSU become unstable. Interestingly, it appears that the sedimentation profile has generally been restored in the dKO TbMrf1 7wk cell line, even though the recovery of the 9S rRNA trails that of the 12S rRNA.
The supramolecular organization of the FoF1-ATPase can be visualized when hypotonically isolated mitochondria are lysed with n-dodecyl-β-D-maltoside (DDM), resolved by light blue native (BN) electrophoresis and then transferred to a PVDF blot that is probed with serum that recognizes components of either the Fo or F1 moieties. In the absence of subunit A6, the higher molecular weight structures of the intact FoF1-ATPase are destabilized under the aforementioned conditions41,42. Strikingly, the dKO TbMrf1 1wk FoF1-ATPase monomers and oligomers are drastically reduced compared to the parental enzyme, whereas F1 accumulates (Fig. 2c). In addition, there is a recovery of the ATPase monomers in the dKO TbMrf1 7wk cell line. To demonstrate equal loading between the different cell lines, the same DDM-lysed mitochondria were also resolved by SDS-PAGE and transferred to membranes that were immunodecorated with a mtHSP70 monoclonal antibody (Fig. 2d). Furthermore, the decreased steady state expression of specific Fo subunits (Fig. 2d) in these denatured samples correlates with the loss of ATPase monomers and dimers visualized by BN westerns. On the other hand, components of the F1 catalytic moiety and the TbAAC transporter responsible for supplying this enzyme with its ATP substrate remain unchanged.
Despite reduced ATPase monomers, dKO TbMrf1 cells still rely on the proton pumping activity of the remaining intact enzymes
While the stability of the FoF1-ATPase monomers and oligomers is greatly reduced in the dKO TbMrf1 1wk culture, these structures are still detected. To determine if these DDM-resistant complexes contribute to cell viability, an Alamar Blue assay was performed to calculate the EC50 of oligomycin. This potent inhibitor binds at the interface of subunit c and A6, thereby blocking the proton translocation of intact FoF1-ATPase43. Even though BF 427 parasites are highly sensitive to oligomycin because they depend on the FoF1-ATPase activity to pump protons that maintain the ∆ψm, the dKO TbMrf1 1wk cells are several orders of magnitude more sensitive to this antibiotic (Fig. 3, Table 2). Once again, the dKO TbMrf1 7wk culture demonstrates an intermediate phenotype as the oligomycin EC50 increases towards the values measured in the parental cell line.
Destabilization of intact FoF1-ATPase complexes only partially diminishes the ∆ψm
In BF T. brucei mitochondria, the intact FoF1-ATPase hydrolyzes ATP and pumps protons into the mt intermembrane space to maintain the essential ∆ψm. Since the absence of TbMrf1 leads to the partial destabilization of FoF1-ATPase monomers and dimers, the relative ∆ψm was determined by staining these cell lines with TMRE and measuring the fluorescence produced from the ∆ψm dependent probe. Compared to BF 427 cells, the ∆ψm was diminished ~35% in the dKO TbMrf1 1wk cells (Fig. 4a), which most likely contributed to the mild growth phenotype seen in these cells. Furthermore, the ∆ψm of the dKO TbMrf1 7wk cells returned to within ~15% of BF 427 values, which correlates with the increased stability observed in the FoF1-ATPase monomers in these parasites (Fig. 2c).
While there were dramatically fewer intact FoF1-ATPases to maintain the ∆ψm in the dKO TbMrf1 1wk cell line (Fig. 2c), the depolarization of the inner mt membrane was not as drastic as when a subunit of the catalytic F1 moiety is depleted25,44. Therefore, we hypothesized that the mt bioenergetics of dKO TbMrf1 1wk cells might more closely resemble Dk trypanosomes, where the dependence on the electrogenic exchange of cytosolic ATP4- for mt ADP3− by TbAAC becomes magnified. To assess this possibility, we employed an Alamar Blue assay to measure the EC50 of carboxyatractyloside (CATR), an inhibitor of AAC, in BF 427 cells, dyskinetoplastic T. evansi and the dKO TbMrf1 cell lines. While there is no significant change in the steady state levels of TbAAC expression when the parasite lacks TbMrf1 (Fig. 2d), the sensitivity to CATR is drastically increased in the dKO TbMrf1 1wk cells to almost the same levels observed in T. evansi (Fig. 4b, Table 2). Furthermore, the intermediate CATR EC50 values measured in the dKO TbMrf1 7wk cells correlates with the observed increased levels of intact FoF1-ATPase monomers in these parasites.
Dk trypanosomes are able to lose their mt genomes because they contain compensatory mutations within specific F1-ATPase subunits. However, when we sequenced the γ subunit from dKO TbMf1 7wk culture, no mutations including the ones known for Dk cells26 were observed (data not shown). Furthermore, the completed genome of the dyskinetoplastic T. evansi strain STIB805 revealed that there are only two notable amino acid substitutions in the α (G510C) and β (N395S) subunits45, but neither one was detected in our sequencing data from the dKO TbMrf1 7wk cell line. In fact, unlike yeast Mrf1 mutants that display a rapid lost of mt DNA, the DAPI staining of fixed T. brucei lacking TbMrf1 did not result in cells without kinetoplast DNA (Supplementary Fig. S1). Furthermore, the dKO TbMrf1 cell lines are slightly more sensitive than BF 427 cells to acriflavin, a lethal DNA intercalator that predominantly accumulates in the mt DNA (Table 2). Finally, the calculated oligomycin EC50 value of the dyskinetoplastic T. evansi (Table 2) indicates that unlike the dKO TbMrf11wk cell line, these parasites are even less sensitive to oligomycin than BF 427. Altogether, this would suggest that the dKO TbMrf1 mutants are still dependent on their mt genome expression.
To confirm that the observed phenotypes measured were truly due to the loss of TbMrf1, we generated a conditional knockout (cKO) TbMrf1 7wk cell line with heterologous expression of a C-terminally V5-tagged TbMrf1 that was verified by western blot analysis with a V5 antibody (Supplementary Fig. S2a). This cell line demonstrated that despite the epitope tag, tetracycline induced ectopic TbMrf1 expression largely restored the oligomycin and carboxyatracrtyloside EC50 values to BF 427 levels (Supplementary Fig. S2b, Table 2).
TbMrf1 deficient parasites are avirulent in the mouse model
While dKO TbMrf1 cell lines are able to cope with a significant loss of intact FoF1-ATPase complexes and remain viable when grown in culture, we questioned whether these parasites would be virulent when introduced into an animal model with an active immune system. Therefore, we infected 3 groups of 5 BALB/c mice with 1 × 105 BF 427 or dKO TbMrf1 1wk or 7wk parasites. The survival rate was monitored and parasitemia levels were calculated from blood samples obtained via tail pricks. While none of the mice infected with BF 427 trypanosomes survived past day 6, neither set of mice infected with either dKO TbMrf1cell line succumbed to disease after 30 days (Fig. 5a). This discrepancy was further illustrated in the parasitemia levels, where BF 427 cells were quickly able to reach lethal levels (>1 × 108 trypanosomes/ ml blood), while only very low levels of dKO TbMrf1parasites were sporadically detected throughout the length of the experiment (Fig. 5b). Thus, while convenient, measuring the growth phenotypes of genetically modified trypanosomes in culture does not always depict the true importance of a protein function, especially in the case of gene products that can potentially disrupt bioenergetic processes of the cell.
Overexpression of release factor TbPth4 partially alleviates the dKO TbMrf1 phenotypes
The viability of the dKO TbMrf1 cell line in culture suggests the presence of another factor that is able to compensate for the loss of TbMrf1 and ensure some mt translation termination. In S. pombe, it has been demonstrated that the peptidyl-tRNA hydrolase Pth4 plays an overlapping role with Mrf136. A protein BLAST search on TriTrypDB revealed that TbPth4 (Tb927.6.2500), which contains a release factor domain, is the most obvious T. brucei ortholog of the yeast protein as they share 36% similarity and 21% identity (MUSCLE alignment). To ascertain if the function of TbPth4 becomes more important when the mt translation appartus becomes impaired, we monitored its gene expression in the dKO TbMrf1 cell lines. Since we lack an antibody that recognizes TbPth4, we employed qPCR to analyze the levels of mRNA in the dKO TbMrf1 cell lines compared to BF 427. Using β-tubulin as an internal control, a very modest increase of TbPth4 mRNA was observed in the absence of TbMrf1 (Fig. 6a). However, compared to the considerable Pth4 mRNA expression observed in the tetracycline induced dKO TbMrf1 cell line overexpressing a V5-tagged ectopic TbPth4, this slight uptick may not translate into any biological significance in the dKO TbMrf1 parasites.
Since the overexpression of the S. pombe Pth4 helps to alleviate the phenotypes induced by the loss of Mrf136, we explored if the same could be true in T. brucei. While the dKO TbMrf1 1wk cell line demonstrates the largest phenotypic changes compared to BF 427, we have demonstrated that the severity of these measured outcomes reduces over time as the cells are maintained in culture. Therefore, due to the length of time involved in selecting transfected T. brucei and verifying positive clonal cell lines, it was not feasible to generate the ectopic V5-tagged TbPth4 in the dKO TbMrf1 1wk cell line. However, when the V5-tagged TbPth4 is overexpressed in the dKO TbMrf1 7wk background, the doubling time continues to return towards WT values (Fig. 6b,c). We also determined from additional Alamar Blue assays that the increased sensitivity to oligomycin and carboxyatractyloside observed in the dKO TbMrf1 cell lines is reduced when the ectopic TbPth4 is induced (Fig. 6d,e, Table 2).
Since TbPth4 has not been characterized previously, we analyzed the subcellular localization of the release factor. An immunoflourescence assay determined that the dKO TbMrf1 + V5 Pth4 is colocalized with the F1-ATPase subunit β in the mitochondrion (Fig. 6f). Furthermore, the tagged TbPth4 was tracked in a Western blot analysis of fractions generated from a carbonate extraction of enriched mitochondria isolated by hypotonic lysis of the parasite. The specificity of the resulting subcellular fractions was verified using enolase as a cytosolic marker; while MRP1, ATPase subunit β and TbAAC represented mt proteins with various propensities for either the mt inner membrane or the matrix. This analysis reveals that TbPth4 is largely localized in the mt matrix (Fig. 6g).
Depletion of TbPth4 exacerbates the phenotypes identified in BF T. brucei lacking TbMrf1
To determine if TbPth4 is involved in the rescue of an impaired mt translation system missing TbMrf1, we depleted this release factor in both BF 427 single marker (SM) and dKO TbMrf1 7wk cells using a stem loop RNAi vector. While there was a very modest increase in the doubling time observed in the RNAi induced BF 427 SM cells (Fig. 7a), there was a striking growth phenotype when TbPth4 is abated in the dKO TbMrf1 7wk cell line (Fig. 7b). A qPCR analysis verified that the TbPth4 transcript is similarly reduced in both cell lines. Typical of the RNAi system in T. brucei, the dKO TbMrf1 + RNAi TbPth4 culture escaped the RNAi regulation around day 10 of tetracycline induction.
We further characterized the dKO TbMrf1 + RNAi TbPth4 cell line by once again observing what happens to the structural integrity of the mitoribosomes. Since the parental cell line is the dKO TbMrf1 7wk culture, the uniduced RNAi cells display a fairly normal and broad sedimentation profile of the 9S and 12S rRNA on a glycerol gradient (Fig. 7c,d). By day 3 of the TbPth4 RNAi induction, the levels of both rRNAs are reduced, with a greater impact on the RPS12 associated 9S SSU peak. There are also two distinct rRNA peaks that presumably represent the individual SSU and LSU subcomplexes (45S) and the higher S-value (80S) monosome fraction associated with mRNA. However, after depleting TbPth4 for 5 days, the 80S rRNA peak is largely reduced and all that remains is a diminished broad peak centered around the lower 45S fractions. These results would suggest that the partially restored WT-like mitoribosome profile observed in the dKO TbMrf1 7wk cell line has been eliminated with the loss of TbPth4.
To understand how an impeded mt translation system could result in a cytostatic dKO TbMrf1 + RNAi TbPth4 cell line, we observed the supramolecular organization of the FoF1-ATPase by probing Western blots generated from light blue native gels with serum that recognize distinct ATPase moieties. Unlike the dKO TbMrf1 7wk cells that had recovered some of the FoF1-ATPase monomers, the monomers and dimers of this proton pumping enzyme are virtually undetectable by day 3 and 5 of TbPth4 RNAi induction (Fig. 7e). This result is further exemplified by the steady-state Western analysis of these same DDM-lysed mitochondria resolved on SDS-PAGE, which demonstrate that the Fo subunit OSCP that couples the catalytic activity of the F1 region to the proton pumping activity is not visualized upon the induction of TbPth4 RNAi (Fig. 7f). With little to no intact FoF1-ATPase with a functional proton pore that can directly contribute to the ∆ψm, the measured relative ∆ψm of the induced dKO TbMrf1 + RNAi TbPth4 cells drops to 50% of wildtype levels (Fig. 7g).
Discussion
Despite the severe growth phenotype previously observed in cultured PF T. brucei depleted of TbMrf140, we were able to generate in vitro BF parasites without this release factor. Confronted with an intriguing BF cell line that can tolerate the elimination of TbMrf1, but without any direct means of ascertaining how mt translation termination was affected, we chose to characterize mitochondrial phenotypes that could rationally be attributed to the loss of a release factor. In fact, it was indirect evidence that originally assigned the expected function of TbMrf1 when it was shown that oxidative phosphorylation (OXPHOS) is disturbed upon TbMrf1 RNAi induction40. Unfortunately, even this assay is impractical when working with BF trypanosomes, so we decided to look at the integrity of two essential complexes in the BF mitochondrion that contain a solitary mt encoded subunit. Indeed, this is not unprecedented as the stability and composition of the mitoribosomes and FoF1-ATPase has been extensively characterized when mt gene expression is impeded7,42.
With this rationale, we interpreted the significant disruption of intact mitoribosomes and FoF1-ATPases in the dKO TbMrf1 1wk cell line to indirectly indicate that mt translation has been impaired. The instability of the FoF1-ATPase monomer and dimers is most likely due to the abated protein expression of the Fo integral membrane subunit A6, which causes the complex to become more labile in the presence of detergent41,42,46. However, since the dKO TbMrf1 parasites are hypersensitive to oligomycin and thus still depend on the proton pumping function of the remaining intact FoF1-ATPase enzymes, we believe that mt translation is not completely blocked. This analysis is further supported by the observations that the dKO TbMrf1 cells retain some intact FoF1-ATPases, do not lose their mt DNA, display increased sensitivity to acriflavin and do not possess any of the required γ mutations previously catalogued in dyskinetoplastic trypanosomes26.
The ability of the dKO TbMrf1 1wk cells to continue to synthesize some amount of subunit A6 in the absence of TbMrf1 presumably allows the parasite to adapt its bioenergetics by relying more heavily on TbAAC to produce an electrogenic exchange of cytosolic ATP4− for mt ADP3−, which can compensate for the decrease in intact FoF1-ATPase complexes containing a functioning proton pore. Indeed, it appears that there is a delicate equilibrium that is maintained between the amount of proton pumping FoF1-ATPase enzymes and the activity levels of TbAAC to maintain the ∆ψm as evidenced by the increased levels of intact FoF1-ATPase monomers in the dKO TbMrf1 7wk cells and the intermediate CATR EC50 values observed for these parasites.
This unique compensatory mechanism can occur in the BF trypanosoma mitochondrion because of the unusal dependence on the FoF1-ATPase to continually hydrolyze ATP to maintain the essential ∆ψm required for mt protein import47. However, this comes at a large energetic cost to the parasite. Therefore, it is pertinent to understand how much of a ∆ψm is needed to maintain sufficient protein and metabolite (e.g. pyruvate) import for key mt processes48. By thoroughly characterizing these dKO TbMrf1cell lines, we propose that in vitro BF trypanosoma cell cultures can tolerate a substantial decrease in their ∆ψm as long as it remains above a minimal threshold, which we predict is between 50–65% of WT ∆ψm values. While this allows the parasite to survive in culture, it is no longer a viable option when the T. brucei dKO TbMrf1 is introduced into an animal model, probably because the parasite has greater energetic requirements when it needs to evade the host’s immune system49. Under these conditions, even the dKO TbMrf1 7wk parasites, observed to possess 85% of the WT ∆ψm when grown in vitro, are unable to establish a lethal infection in a mouse.
Canonical translation termination occurs when Mrf1 recognizes a stop codon in the A site and hydrolyzes the ester bond between the P site tRNA and the nascent polypeptide. However, ribosomes can become stalled when they encounter truncated mRNA or transcripts that contain nonstop mutations or rare codons50. Pth4 is a yeast codon-independent release factor that is described as a versatile mitoribosome rescue factor that is involved in recycling these stalled ribosomes. The observed phenotypes in both the induced dKO TbMrf1 + V5 Pth4 and dKO TbMrf1 + RNAi TbPth4 cell lines provide tantalizing evidence that TbPth4 is able to recognize that the dKO TbMrf1 mitoribosome has become stalled at the UAG stop codon and is able to release the completed polypeptide to create a sufficient amount of RPS12 and subunit A6.
While Pth4 homologs are found throughout bacteria and eukaryotic mitochondria36,37,51, it appears that they probably function via different molecular mechanisms. For example, it has been demonstrated that upon RNAi depletion of the Pth4 mammalian ortholog (ICT1), cell viability is greatly affected as well as the stability of mt encoded subunits of OXPHOS complexes, in particular cytochrome c oxidase37. However, the deletion of Pth4 in S. pombe caused no reduction in cell proliferation even when grown on media containing only non-fermentable carbon sources. Similarly, the silencing of TbPth4 in BF 427 T. brucei did not generate a significant growth effect.
It is currently unclear how this ribosome integrated release factor is able to gain access to the distant PTC and become catalytically active. The LSU bound ICT1 may be restricted to an architectural role, while soluble forms of the protein are able to bind the mitoribosomal A site and perform peptidyl-tRNA hydrolysis50. While no free pool of the ICT1 has yet to be detected in the mammalian mt matrix, ectopic expression of TbPth4 in T. brucei is prodominantly localized in the soluble mt fraction. This would suggest that the mechanism of TbPth4 will be more similar to yeast, which also has a fraction of the release factor that is unassociated with the mitoribosome. The overexpression of TbPth4 in the dKO TbMrf1 background likely increased the overall amount of the protein, most of which probably contributed to a pool of unbound release factor that was available to bind the empty A site of stalled mitoribosomes. However, this only produced mild decreases in the observed dKO TbMrf1 phenotypes, suggesting that this emergency release factor is not overly efficient at rescuing stalled ribosomes. This would perhaps explain why TbPth4 was not able to replace the loss of TbMrf1 in the procyclic stage of the parasite, where the bioenergetic needs of the active mitochondrion requires robust translation of nearly all 18 mt encoded transcripts. Additional studies are being pursued to determine the molecular mechanism in which TbPth4, a release factor without a codon recognition domain, is able to terminate translation at a stop codon.
Methods
Transgenic T. brucei cell cultures
The bloodstream form T. brucei brucei Lister 427 strain (information about the identity and genealogy of this strain is available at http://tryps.rockefeller.edu) and the dyskinetoplastic strain T. b. evansi Antat 3/352 were cultured in HMI-9 media containing 10% FBS and incubated in a 37 °C incubator with 5% CO2. The BF 427 single marker (SM) cell line, constitutively expressing the ectopic copy of T7 RNA polymerase and tetracycline repressor, was used for the tetracycline inducible expression of dsRNA and V5-tagged proteins53. This expression system was induced by the addition of 1 μg/ml of tetracycline into the media. Cell densities were monitored using the Z2 Cell Counter (Beckman Coulter Inc.) and maintained in the mid-log phase (between 1 × 105 to 1 × 106 cells/ml). Growth curves depicting the cumulative cell number of the cultures were calculated from the measured cell densities that were adjusted by the dilution factor needed to seed the cultures at 1 × 105 cells/ml each day.
The generation of a TbMrf1 double knockout (dKO) cell line involved replacing both alleles of the TbMrf1 gene (Tb927.3.1070) with either a neomycin or hygromycin resistance gene cassette derived from the pLEW13 and pLEW90 vectors, respectively53. To direct the homologous recombination to the TbMrf1 alleles, these knockout (KO) cassettes were flanked by short sequences of the TbMrf1 5′ (469 nt) and 3′ (540nt) untranslated region (UTR) that were identified with TritrypDB (version Tb927_3_V5.1). These UTR fragments were PCR amplified from BF 427 genomic DNA (gDNA) with either the 5′UTR_fw&rv or the 3′UTR_fw&rv primer pairs (Supplementary Table S1). The amplicons were then digested either with NotI and MluI endonucleases (5′ UTR) or XbaI and StuI (3′ UTR) before sequentially being ligated into the neomycin-resistance cassette containing the T7 polymerase gene. The final pLEW13_TbMrf1_3′/5′UTRs_neomycin construct was linearized with NotI and electroporated with human T cell nucleofactor solution (AMAXA) into BF 427 to generate a single knockout (sKO) cell line. To create near-clonal cell lines, the transfected cells were serially diluted after 16 hours of recovery and selected with 2.5 μg/ml neomycin. The gDNA from stable transgenic cell lines that arose after ~2 weeks of selection was isolated using the GenElute Mammalian Genomic DNA Miniprep Kits from Sigma. The correct integration of the sKO cassette into the TbMrf1 allele was verified by PCR with the following primer pairs that bridge either the 5′ or 3′ integration sites: 5′UTR_ext_fw and sKO_rv; sKO_fw and 3′UTR_ext_rv (Fig. 1a,b, Supplementary Table S1).
The hygromycin-resistance cassette containing the tetracycline repressor was excised from the pLEW90 vector with XhoI and StuI endonucleases. This cassette was then used to replace the neomycin-resistance cassette from the pLEW13_TbMrf1_3′/5′UTRs_neomycin vector, which was digested with XhoI and SwaI restriction enzymes. The resulting construct pLEW13_TbMrf1_3′/5′UTRs_hygromycin was linearized with NotI and the dKO cassette was transfected into the verified TbMrf1_sKO cell line. Selection with 25 μg/ml of hygromycin resulted in stably transfected cell lines termed TbMrf1_dKO. To verify that both TbMrf1 alleles had been replaced, isolated gDNA served as a PCR template to produce amplicons with primer pairs that bridge the 5′ and 3′ integration sites of both selectable markers (5′UTR_ext_fw and dKO_rv; dKO_fw and 3′UTR_ext_rv) (Fig. 1a,b, Supplementary Table S1). The elimination of the TbMrf1 open reading frame (ORF) from the genome was confirmed by PCR using ORF-specific primers (TbMrf1_fw and rv).
A conditional knockout (cKO) cell line with heterologous expression of a C-terminal 3xV5-tagged TbMrf1 in the dKO TbMrf1 7wk background was also generated. The TbMrf1 ORF was amplified from gDNA with the primers TbMrf1 cKO_fw and TbMrf1 cKO_rv (Supplementary Table S1). The resulting amplicon was digested with BamHI and HindIII before being ligated into a similarly digested pT7-3V5-PAC vector containing the puromycin resistance gene (PAC)54. The sequenced-verified construct was transfected into the dKO TbMrf1 7wk cell line and the transgenic trypanosomes were selected with 0.1 μg/ml of puromycin. These selected transgenic parasites were termed cKO TbMrf1 once it was verified by Western blot that tetracycline induced cells displayed the ectopic V5 TbMrf1 protein. This regulatable expression system is possible due to the previous TbMrf1 allelic replacements with the T7 polymerase and the tetracycline repressor.
In a similar manner, a dKO TbMrf1 + V5 TbPth4 (Tb927.6.2500) transgenic cell line was generated using the following forward (fw) and reverse (rv) primers: TbPth4V5_fw and TbPth4V5_rv (Supplementary Table S1).
To silence the expression of the TbPth4 gene by double stranded RNA interference (RNAi), we employed a construct that inducibly expresses a stem loop RNA with T7 RNA polymerase. The original pRPhyg-iSL vector (courtesy of Sam Alsford) was adapted to our needs by replacing the hygromycin resistance gene with the ble gene that provides resistance to phleomycin. A 501 nt fragment of TbPth4 that includes a portion of the 5′UTR and CDS (−55 nt to 446 nt) was amplified with a primer pair containing the restrictions sites SmaI and XhoI on the forward oligonucleotide, while the reverse contained BamHI and HindIII sites (TbPth4iSL_fw and rv). By digesting the same amplicon with either SmaI and BamHI or XhoI and HindIII, it could be sequentially ligated into the vector so that it was inserted twice in a head-to-head orientation, which would create a hairpin structure upon tetracycline-induced transcription. The transfection of the™ NotI-linearized pRPphleo_TbPth4-iSL construct into SM BF cells and the dKO TbMrf1 7wk cell line resulted in the RNAi TbPth4 and dKO TbMrf1 + RNAi TbPth4 cell lines, respectively. Both of these transgenic cell lines were actively selected using 2.5 μg/ml of phleomycin.
Subcellular fractionation followed by carbonate extraction
Na2CO3 extraction of mt membranes was adapted from a previously published protocols29,55.
Briefly, mt vesicles from 5 × 108 cells were isolated by hypotonic lysis. The mt pellet was further treated with digitonin (80 μg/ml) for 15 min on ice to disrupt the mt outer membrane. The material was then cleared by centrifugation (12,000 g, 20 min, 4 °C) and the pelleted mitoplasts were resuspended in 0.1 M Na2CO3 buffer (pH 11.5) and incubated for 30 min on ice. A final ultracentrifugation step (100,000 g, 4 °C for 1 hr, SW50Ti rotor) resulted in a supernatant comprised of proteins from the mt matrix, including stripped peripheral membrane proteins, and a pellet containing integral proteins isolated from the mt membrane fraction.
Glycerol gradient fractionation
Whole cell lysates were prepared by resuspending 5 × 108 BF cells in 300 µl of lysis buffer (30 mM HEPES pH 7.3, 12 mM MgCl2,120 mM KCl, 1% Nonidet NP40, 1 mM DTT) supplemented with 2 × EDTA-free protease inhibitors (Roche) and RNAseOUT RNAse inhibitor. Lysed cells were treated with TURBO DNAse for 15 minutes on ice and pelleted (21,000 g for 15 min at 4 °C). In the meantime, linear 10–30% glycerol gradients were prepared in thin-wall tubes (Beckman) using a Gradient Station (Biocomp) according to the manufacturer´s protocol. The cleared supernatant (200 μl) was loaded onto the glycerol gradient and centrifuged (38,000 g for 4 hours at 4 °C) in a SW 41 Ti rotor (Beckman Coulter). The Gradient Station was then used to collect 500 µl fractions that were used to isolate total RNA using a standard phenol-chloroform extraction protocol.
Isolation of total RNA, reverse transcription, and qPCR
Quantitative reverse transcription PCR (RT-qPCR) was performed using a Light Cycler® 480 system (Roche) according to the manufacturer’s recommendations. Briefly, total RNA from 1 × 107 BF cells was extracted as described earlier and 10 μg were treated with TURBO DNAse (Ambion). The excess DNase was then removed using an RNAeasy kit (Qiagene). Following the manufacturer’s instructions, two micrograms of total RNA was reverse transcribed using the TaqMan Reverse Transcription kit (ABI). 100 ng of the resulting cDNA (2 μl) was mixed with SYBR Green (Applied Biosystems) and specific primers for either the TbPth4 transcript or the internal control transcripts that included 18S rDNA and β-tubulin (Supplementary Table S1). The samples were analyzed on a Light Cycler 480 (Roche) and the relative fold changes in the target amplicons were determined using the Pfaffl method, with the PCR efficiencies calculated by linear regression56.
SDS-PAGE and Western blot analysis
Protein samples were separated by SDS-PAGE on a 12% Tri-Glycine acrylamide gel, blotted onto a PVDF membrane (BioRad) and probed with the appropriate monoclonal (mAb) or polyclonal (pAb) antibody. This was followed by incubation with a secondary HRP-conjugated anti-rabbit or anti-mouse antibody (1:2000, BioRad). Proteins were visualized using the Clarity ECL system (Bio-Rad) on a ChemiDoc instrument (BioRad). The Page Ruler pre-stained protein ladder (Thermo Scientific) was used to determine the size of detected bands. Primary antibodies used in this study included the mAb anti-V5 epitope tag (1:2000, Invitrogen), mAb anti-mtHsp70 (1:2000)57, pAb anti-MRP1 (1:1000)58, pAb anti-AAC (1:2000)59, and pAb anti-enolase (1:1000)60. Additionally, the following pAbs were produced in our laboratory: anti-APRT (1:500), anti-ATPaseTb2 (1:1000), anti-OSCP (1:500), anti-β subunit (1:2000) and anti-p18 (1:1000)29.
Light blue native electrophoresis (BN PAGE)
Hypotonically isolated crude mt vesicles from 5 × 108 BF trypanosomes were resuspended in 1 M aminocaproic acid (ACA) and lysed with 2% dodecyl-maltoside for one hour on ice. The samples were pelleted at 16,000 g for 30 min and the protein concentrations were determined by a Bradford assay. Equal amounts of protein for each sample were mixed with loading dye (0.5 M ACA, 5% w/v commassie G-250) and loaded onto a 3%–12% BisTris native gradient acrylamide gel. Two different native running buffers were used, a cathode buffer (50 mM tricine, 15 mM BisTris, 0.002% of Coommassie Blue) and an anode buffer (50 mM BisTris), both at pH 7. After electrophoresis (3 hr, 100 V, 4 °C), the resolved mt proteins were transferred onto a nitrocellulose membrane (90 min, 90 V, 4 °C, stirring) and probed with specific pAbs against FoF1-ATPase subunits: β, OSCP, ATPaseTb2, and p18.
Mt membrane potential (Δψm) measurement
The Δψm was determined utilizing the red-fluorescent stain tetramethylrhodamine ethyl ester (TMRE, Invitrogen). Cells in the exponential growth phase were stained with 60 nM of the dye for 30 min at 37 °C. Each time, 1 × 105 cells were pelleted (1,300 g, 10 min, room temperature), resuspended in 1 ml of PBS (pH 7.4) and immediately analyzed by flow cytometry (BD FACS Canto II Instrument). For each sample, 10,000 fluorescent events were collected. Treatment with the protonophore FCCP (20 μM) for 10 min was used as a control for mt membrane depolarization. Data were evaluated using BD FACSDiva (BD Company) software.
Drug sensitivity assay
Drug sensitivity assays using the resazurin sodium salt dye (Alamar Blue assay) were performed according to a published protocol61. Tested inhibitors dissolved in HMI-9 media (i.e. oligomycin and carboxyatractyloside, SIGMA) were serially diluted 2 fold across each column of a 96-well plate. Individiual wells were then seeded with either 5 × 103 BF 427 cells or 1 × 104 dKO TbMrf11wk/7wk cells, resulting in a total volume of 200 µl of HMI-9 media. The plates were incubated for 72 hours at 37 °C with 5% CO2. Finally, 20 µl of resazurin (0.125 mg/ml in 1xPBS, pH 7.4) was added to each well and the plate was further incubated for 8 hours. Fluorescence was measured on the Infinite M100 plate reader (Tecan) at excitation and emission wavelengths of 560 and 590 nm, respectively. Using GraphPad Prism 5.0, data were analyzed by non-linear regression with a variable slope.
Survival analysis in an animal model
Three groups of 5 female BALB/c mice were infected via a 200 µl intraperitoneal injection of 1 × 105 BF 427, dKO TbMrf11wk or 7wk trypanosomes. Parasitemia levels of individual animals were monitored daily for 7 days. Blood samples from a tail prick were diluted 100 times in TrypFix solution (1X SSC, 3.7% formaldehyde) and the number of parasites were quantified using an improved Neubauer haemocytometer. Mice displaying impaired health and/or a parasite load >108 cells/ml of blood were euthanized. Survival of the experimental group was visually monitored for up to 30 days. The data were analyzed with the built-in survival analysis on GraphPad Prism 5.0.
All data generated or analyzed during this study are included in this published article (and its Supplementary Information file).
References
Matthews, K. R. 25 years of African trypanosome research: From description to molecular dissection and new drug discovery. Mol Biochem Parasitol 200, 30–40, https://doi.org/10.1016/j.molbiopara.2015.01.006 (2015).
Jensen, R. E. & Englund, P. T. Network news: the replication of kinetoplast DNA. Annu Rev Microbiol 66, 473–491, https://doi.org/10.1146/annurev-micro-092611-150057 (2012).
Read, L. K., Lukes, J. & Hashimi, H. Trypanosome RNA editing: the complexity of getting U in and taking U out. . Wiley interdisciplinary reviews. RNA 7, 33–51, https://doi.org/10.1002/wrna.1313 (2016).
Blum, B., Bakalara, N. & Simpson, L. A model for RNA editing in kinetoplastid mitochondria: “guide” RNA molecules transcribed from maxicircle DNA provide the edited information. Cell 60, 189–198 (1990).
Seiwert, S. D., Heidmann, S. & Stuart, K. Direct visualization of uridylate deletion in vitro suggests a mechanism for kinetoplastid RNA editing. Cell 84, 831–841 (1996).
Aphasizheva, I. et al. Ribosome-associated pentatricopeptide repeat proteins function as translational activators in mitochondria of trypanosomes. Mol Microbiol 99, 1043–1058, https://doi.org/10.1111/mmi.13287 (2016).
Aphasizheva, I., Maslov, D. A. & Aphasizhev, R. Kinetoplast DNA-encoded ribosomal protein S12: A possible functional link between mitochondrial RNA editing and translation in Trypanosoma brucei. RNA Biol 10, 1679–1688, https://doi.org/10.4161/rna.26733 (2013).
Zikova, A. et al. Trypanosoma brucei mitochondrial ribosomes: affinity purification and component identification by mass spectrometry. Mol Cell Proteomics 7, 1286–1296, https://doi.org/10.1074/mcp.M700490-MCP200 (2008).
de la Cruz, V. F., Lake, J. A., Simpson, A. M. & Simpson, L. A minimal ribosomal RNA: sequence and secondary structure of the 9S kinetoplast ribosomal RNA from Leishmania tarentolae. Proc Natl Acad Sci USA 82, 1401–1405 (1985).
de la Cruz, V. F., Simpson, A. M., Lake, J. A. & Simpson, L. Primary sequence and partial secondary structure of the 12S kinetoplast (mitochondrial) ribosomal RNA from Leishmania tarentolae: conservation of peptidyl-transferase structural elements. Nucleic Acids Res 13, 2337–2356 (1985).
Sharma, M. R., Booth, T. M., Simpson, L., Maslov, D. A. & Agrawal, R. K. Structure of a mitochondrial ribosome with minimal RNA. Proc Natl Acad Sci USA 106, 9637–9642, https://doi.org/10.1073/pnas.0901631106 (2009).
Hancock, K. & Hajduk, S. L. The mitochondrial tRNAs of Trypanosoma brucei are nuclear encoded. J Biol Chem 265, 19208–19215 (1990).
Schneider, A. Mitochondrial tRNA import and its consequences for mitochondrial translation. Annu Rev Biochem 80, 1033–1053, https://doi.org/10.1146/annurev-biochem-060109-092838 (2011).
Maslov, D. A. et al. An intergenic G-rich region in Leishmania tarentolae kinetoplast maxicircle DNA is a pan-edited cryptogene encoding ribosomal protein S12. Mol Cell Biol 12, 56–67 (1992).
Ogle, J. M. et al. Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292, 897–902, https://doi.org/10.1126/science.1060612 (2001).
Ogle, J. M. & Ramakrishnan, V. Structural insights into translational fidelity. Annu Rev Biochem 74, 129–177, https://doi.org/10.1146/annurev.biochem.74.061903.155440 (2005).
Schmeing, T. M. et al. The crystal structure of the ribosome bound to EF-Tu and aminoacyl-tRNA. Science 326, 688–694, https://doi.org/10.1126/science.1179700 (2009).
Cukras, A. R., Southworth, D. R., Brunelle, J. L., Culver, G. M. & Green, R. Ribosomal proteins S12 and S13 function as control elements for translocation of the mRNA:tRNA complex. Mol Cell 12, 321–328 (2003).
Horvath, A., Nebohacova, M., Lukes, J. & Maslov, D. A. Unusual polypeptide synthesis in the kinetoplast-mitochondria from Leishmania tarentolae. Identification of individual de novo translation products. J Biol Chem 277, 7222–7230, https://doi.org/10.1074/jbc.M109715200 (2002).
Skodova-Sverakova, I., Horvath, A. & Maslov, D. A. Identification of the mitochondrially encoded subunit 6 of FF ATPase in Trypanosoma brucei. Mol Biochem Parasitol 201, 135–138, https://doi.org/10.1016/j.molbiopara.2015.08.002 (2015).
Dean, S., Gould, M. K., Dewar, C. E. & Schnaufer, A. C. Single point mutations in ATP synthase compensate for mitochondrial genome loss in trypanosomes. Proc Natl Acad Sci USA 110, 14741–14746, https://doi.org/10.1073/pnas.1305404110 (2013).
Tielens, A. G. & van Hellemond, J. J. Surprising variety in energy metabolism within Trypanosomatidae. Trends Parasitol 25, 482–490, https://doi.org/10.1016/j.pt.2009.07.007 (2009).
Clarkson, A. B. Jr., Bienen, E. J., Pollakis, G. & Grady, R. W. Respiration of bloodstream forms of the parasite Trypanosoma brucei brucei is dependent on a plant-like alternative oxidase. J Biol Chem 264, 17770–17776 (1989).
Chaudhuri, M., Ajayi, W. & Hill, G. C. Biochemical and molecular properties of the Trypanosoma brucei alternative oxidase. Mol Biochem Parasitol 95, 53–68, https://doi.org/10.1016/S0166-6851(98)00091-7 (1998).
Schnaufer, A., Clark-Walker, G. D., Steinberg, A. G. & Stuart, K. The F1-ATP synthase complex in bloodstream stage trypanosomes has an unusual and essential function. EMBO J 24, 4029–4040, https://doi.org/10.1038/sj.emboj.7600862 (2005).
Lai, D. H., Hashimi, H., Lun, Z. R., Ayala, F. J. & Lukes, J. Adaptations of Trypanosoma brucei to gradual loss of kinetoplast DNA: Trypanosoma equiperdum and Trypanosoma evansi are petite mutants of T. brucei. Proc Natl Acad Sci USA 105, 1999–2004, https://doi.org/10.1073/pnas.0711799105 (2008).
Pena-Diaz, P. et al. Functional Characterisation of TbMCP5, a Conserved and Essential ADP/ATP Carrier Present in the Mitochondrion of the Human Pathogen Trypanosoma brucei. J Biol Chem. https://doi.org/10.1074/jbc.M112.404699 (2012).
Gnipova, A. et al. The ADP/ATP carrier and its relationship to oxidative phosphorylation in ancestral protist trypanosoma brucei. Eukaryot Cell 14, 297–310, https://doi.org/10.1128/EC.00238-14 (2015).
Subrtova, K., Panicucci, B. & Zikova, A. ATPaseTb2, a unique membrane-bound FoF1-ATPase component, is essential in bloodstream and dyskinetoplastic trypanosomes. PLoS Pathog 11, e1004660, https://doi.org/10.1371/journal.ppat.1004660 (2015).
Ito, K., Uno, M. & Nakamura, Y. A tripeptide ‘anticodon’ deciphers stop codons in messenger RNA. Nature 403, 680–684, https://doi.org/10.1038/35001115 (2000).
Nakamura, Y., Ito, K. & Ehrenberg, M. Mimicry grasps reality in translation termination. Cell 101, 349–352 (2000).
Frolova, L. Y., Merkulova, T. I. & Kisselev, L. L. Translation termination in eukaryotes: polypeptide release factor eRF1 is composed of functionally and structurally distinct domains. RNA 6, 381–390 (2000).
Seit-Nebi, A., Frolova, L., Justesen, J. & Kisselev, L. Class-1 translation termination factors: invariant GGQ minidomain is essential for release activity and ribosome binding but not for stop codon recognition. Nucleic Acids Res 29, 3982–3987 (2001).
Soleimanpour-Lichaei, H. R. et al. mtRF1a is a human mitochondrial translation release factor decoding the major termination codons UAA and UAG. Mol Cell 27, 745–757, https://doi.org/10.1016/j.molcel.2007.06.031 (2007).
Pel, H. J., Maat, C., Rep, M. & Grivell, L. A. The yeast nuclear gene MRF1 encodes a mitochondrial peptide chain release factor and cures several mitochondrial RNA splicing defects. Nucleic Acids Res 20, 6339–6346 (1992).
Dujeancourt, L., Richter, R., Chrzanowska-Lightowlers, Z. M., Bonnefoy, N. & Herbert, C. J. Interactions between peptidyl tRNA hydrolase homologs and the ribosomal release factor Mrf1 in S. pombe mitochondria. Mitochondrion 13, 871–880, https://doi.org/10.1016/j.mito.2013.07.115 (2013).
Richter, R. et al. A functional peptidyl-tRNA hydrolase, ICT1, has been recruited into the human mitochondrial ribosome. EMBO J 29, 1116–1125, https://doi.org/10.1038/emboj.2010.14 (2010).
Kehrein, K. et al. Organization of Mitochondrial Gene Expression in Two Distinct Ribosome-Containing Assemblies. Cell reports. https://doi.org/10.1016/j.celrep.2015.01.012 (2015).
Cristodero, M., Seebeck, T. & Schneider, A. Mitochondrial translation is essential in bloodstream forms of Trypanosoma brucei. Mol Microbiol 78, 757–769, https://doi.org/10.1111/j.1365-2958.2010.07368.x (2010).
Cristodero, M. et al. Mitochondrial translation factors of Trypanosoma brucei: elongation factor-Tu has a unique subdomain that is essential for its function. Mol Microbiol 90, 744–755, https://doi.org/10.1111/mmi.12397 (2013).
Wittig, I. et al. Assembly and oligomerization of human ATP synthase lacking mitochondrial subunits a and A6L. Biochim Biophys Acta 1797, 1004–1011, https://doi.org/10.1016/j.bbabio.2010.02.021 (2010).
Hashimi, H. et al. The assembly of F(1)F(O)-ATP synthase is disrupted upon interference of RNA editing in Trypanosoma brucei. Int J Parasitol 40, 45–54, https://doi.org/10.1016/j.ijpara.2009.07.005 (2010).
Symersky, J., Osowski, D., Walters, D. E. & Mueller, D. M. Oligomycin frames a common drug-binding site in the ATP synthase. Proc Natl Acad Sci USA 109, 13961–13965, https://doi.org/10.1073/pnas.1207912109 (2012).
Gahura, O. et al. The F1 -ATPase from Trypanosoma brucei is elaborated by three copies of an additional p18-subunit. FEBS J, https://doi.org/10.1111/febs.14364 (2017).
Carnes, J. et al. Genome and Phylogenetic Analyses of Trypanosoma evansi Reveal Extensive Similarity to T. brucei and Multiple Independent Origins for Dyskinetoplasty. PLoS Negl Trop Dis 9, e3404, https://doi.org/10.1371/journal.pntd.0003404 (2015).
He, J. et al. Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase. Proc Natl Acad Sci USA, https://doi.org/10.1073/pnas.1702357114 (2017).
Martin, J., Mahlke, K. & Pfanner, N. Role of an energized inner membrane in mitochondrial protein import. Delta psi drives the movement of presequences. J Biol Chem 266, 18051–18057 (1991).
Mazet, M. et al. Revisiting the central metabolism of the bloodstream forms of Trypanosoma brucei: production of acetate in the mitochondrion is essential for parasite viability. PLoS Negl Trop Dis 7, e2587, https://doi.org/10.1371/journal.pntd.0002587 (2013).
Engstler, M. et al. Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes. Cell 131, 505–515, https://doi.org/10.1016/j.cell.2007.08.046 (2007).
Akabane, S., Ueda, T., Nierhaus, K. H. & Takeuchi, N. Ribosome rescue and translation termination at non-standard stop codons by ICT1 in mammalian mitochondria. PLoS genetics 10, e1004616, https://doi.org/10.1371/journal.pgen.1004616 (2014).
Handa, Y., Inaho, N. & Nameki, N. YaeJ is a novel ribosome-associated protein in Escherichia coli that can hydrolyze peptidyl-tRNA on stalled ribosomes. Nucleic Acids Res 39, 1739–1748, https://doi.org/10.1093/nar/gkq1097 (2011).
Borst, P., Fase-Fowler, F. & Gibson, W. C. Kinetoplast DNA of Trypanosoma evansi. Mol Biochem Parasitol 23, 31–38 (1987).
Wirtz, E., Leal, S., Ochatt, C. & Cross, G. A. A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol Biochem Parasitol 99, 89–101 (1999).
Flaspohler, J. A., Jensen, B. C., Saveria, T., Kifer, C. T. & Parsons, M. A novel protein kinase localized to lipid droplets is required for droplet biogenesis in trypanosomes. Eukaryot Cell 9, 1702–1710, https://doi.org/10.1128/EC.00106-10 (2010).
Acestor, N., Panigrahi, A. K., Ogata, Y., Anupama, A. & Stuart, K. D. Protein composition of Trypanosoma brucei mitochondrial membranes. Proteomics 9, 5497–5508, https://doi.org/10.1002/pmic.200900354 (2009).
Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45 (2001).
Panigrahi, A. K. et al. Mitochondrial complexes in Trypanosoma brucei: a novel complex and a unique oxidoreductase complex. Mol Cell Proteomics 7, 534–545, https://doi.org/10.1074/mcp.M700430-MCP200 (2008).
Vondruskova, E. et al. RNA interference analyses suggest a transcript-specific regulatory role for mitochondrial RNA-binding proteins MRP1 and MRP2 in RNA editing and other RNA processing in Trypanosoma brucei. J Biol Chem 280, 2429–2438, https://doi.org/10.1074/jbc.M405933200 (2005).
Singha, U. K. et al. Characterization of the mitochondrial inner membrane protein translocator Tim17 from Trypanosoma brucei. Mol Biochem Parasitol 159, 30–43, https://doi.org/10.1016/j.molbiopara.2008.01.003 (2008).
Hannaert, V. et al. Kinetic characterization, structure modelling studies and crystallization of Trypanosoma brucei enolase. Eur J Biochem 270, 3205–3213 (2003).
Raz, B., Iten, M., Grether-Buhler, Y., Kaminsky, R. & Brun, R. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop 68, 139–147 (1997).
Acknowledgements
This work was funded by Ministry of Education ERC CZ grant LL1205, the EMBO Installation grant no. 1965 to AZ and ERD Fund (No. CZ.02.1.01/0.0/0.0/16_019/0000759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Ruslan Aphasizhev and Inna Aphasizheva (Boston University) for hosting Michaela Procházková in their labs so she could fulfill the research abroad requirement for her PhD studies.
Author information
Authors and Affiliations
Contributions
M.P., B.P. and A.Z. performed the experiments, analyzed data, participated in experiment design. B.P. and A.Z. prepared and edited the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Procházková, M., Panicucci, B. & Zíková, A. Cultured bloodstream Trypanosoma brucei adapt to life without mitochondrial translation release factor 1. Sci Rep 8, 5135 (2018). https://doi.org/10.1038/s41598-018-23472-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-23472-6